Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
10/02/2023 | Deciphera Pharmaceuticals, Inc. | DCPH | Sale | Common Stock | 2.9k | $12.68 | $37.3k | | 10/02/2023 |
01/17/2023 | Deciphera Pharmaceuticals, Inc. | DCPH | Sale | Common Stock | 2.4k | $21.24 | $51k | | 01/17/2023 |
10/03/2022 | Deciphera Pharmaceuticals, Inc. | DCPH | Sale | Common Stock | 2.6k | $18.73 | $48.5k | | 10/03/2022 |
06/22/2022 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 40k | $1.82 | $72.8k | | 06/22/2022 |
06/16/2022 | Deciphera Pharmaceuticals, Inc. | DCPH | Sale | Common Stock | 1.8k | $10.75 | $19k | | 06/16/2022 |
02/16/2022 | Deciphera Pharmaceuticals, Inc. | DCPH | Sale | Common Stock | 984 | $9.05 | $8.9k | | 02/16/2022 |
01/18/2022 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Common Stock | 20.5k | $0.00 | $0 | | 01/18/2022 |
01/18/2022 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 82k | $8.27 | $678.1k | | 01/18/2022 |
12/15/2021 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Common Stock | 11.1k | $0.00 | $0 | | 12/15/2021 |
12/15/2021 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 82.3k | $9.23 | $759.3k | | 12/15/2021 |
10/04/2021 | Deciphera Pharmaceuticals, Inc. | DCPH | Sale | Common Stock | 2.7k | $33.17 | $88.2k | | 10/04/2021 |
06/25/2021 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 40k | $4.00 | $160k | | 06/25/2021 |
02/16/2021 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Common Stock | 11.1k | $0.00 | $0 | | 02/16/2021 |
02/16/2021 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 49.9k | $47.79 | $2.4M | | 02/16/2021 |
02/16/2021 | Deciphera Pharmaceuticals, Inc. | DCPH | Sale | Common Stock | 132 | $48.87 | $6.5k | | 02/16/2021 |
12/09/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Exercise | Stock Option (Right to buy) | 207 | $34.43 | $7.1k | | 12/09/2020 |
11/16/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Exercise | Stock Option (Right to buy) | 2.7k | $34.43 | $92.9k | | 11/16/2020 |
10/02/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Payment of Exercise | Common Stock | 2.6k | $51.15 | $134.6k | | 10/02/2020 |
06/23/2020 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 40k | $3.27 | $130.8k | | 06/23/2020 |
02/18/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Common Stock | 1.8k | $0.00 | $0 | | 02/18/2020 |
02/18/2020 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 10.5k | $54.87 | $577.2k | | 02/18/2020 |
01/25/2020 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 20k | $3.23 | $64.6k | | 01/25/2020 |
10/15/2019 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Common Stock | 35k | $0.00 | $0 | | 10/15/2019 |
10/15/2019 | Deciphera Pharmaceuticals, Inc. | DCPH | Grant | Stock Option (Right to Buy) | 150k | $34.43 | $5.2M | | 10/15/2019 |
05/16/2019 | Pulmatrix, Inc. | PULM | Grant | Stock Option (Right to Buy) | 15k | $1.06 | $15.9k | | 05/16/2019 |
05/10/2019 | LUMOS PHARMA, INC. | NLNK | Grant | Stock Option (Right to Buy) | 25k | $1.69 | $42.2k | | 05/10/2019 |
01/25/2019 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 20k | $2.74 | $54.8k | | 01/25/2019 |
10/24/2018 | PIERIS PHARMACEUTICALS, INC. | PIRS | Grant | Stock Option (right to buy) | 30k | $4.46 | $133.8k | | 10/24/2018 |
06/05/2018 | Pulmatrix, Inc. | PULM | Grant | Stock Option (Right to Buy) | 124k | $0.47 | $58k | | 06/05/2018 |
05/23/2018 | LUMOS PHARMA, INC. | NLNK | Grant | Stock Option (Right to Buy) | 27.8k | $5.33 | $148.1k | | 05/23/2018 |
04/03/2018 | ACCELERON PHARMA INC | XLRN | Sale | Common Stock | 3.7k | $38.28 | $141.6k | | 04/03/2018 |
04/03/2018 | ACCELERON PHARMA INC | XLRN | Sale | Common Stock | 900 | $39.04 | $35.1k | | 04/03/2018 |
04/03/2018 | Pulmatrix, Inc. | PULM | Purchase | Common Stock | 20k | $0.00 | $0 | | 04/03/2018 |
04/03/2018 | Pulmatrix, Inc. | PULM | Purchase | Series A Warrant (right to buy) | 20k | $0.65 | $13k | | 04/03/2018 |
04/03/2018 | Pulmatrix, Inc. | PULM | Purchase | Series B Warrant (right to buy) | 20k | $0.75 | $15k | | 04/03/2018 |
|